Key Drivers
- Profitability surge
- Cash flow strength
- Liability burden
AIAI Summary
OSCR's latest quarter meaningfully upgrades the thesis from “speculative growth” to a real earnings and cash-generating insurer, but with the stock already rerated, the key takeaway is that investors now need several more quarters of stable MLR and underwriting performance to prove this margin inflection is durable rather than a one-off.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Profitability surge
- •Cash flow strength
- •Liability burden
OSCR posted a major Q1 2026 turnaround with strong profit, cash flow, and liquidity gains, but its large liability base and rich book valuation still warrant caution.
Price Behavior
Key Price Behavior Insights:
- •Strong breakout trend
- •Stretched near resistance
- •Pullback risk rising
OSCR has surged sharply over the last month from $15.79 to $23.32 on a steady higher-high/higher-low trend, but the move now looks stretched near $23.70 resistance with support around $22.00–$21.30 and a risk of near-term consolidation.
Rapid ~48% rally from $15.79 to $23.32 suggests short-term stretch and profit-taking risk
Sentiment & News
Key News Insights:
- •Earnings Surge
- •Product Expansion
- •Membership Concerns
Oscar Health is drawing renewed investor interest as a strong Q1 earnings beat, reaffirmed guidance, and product expansion offset concerns about declining membership and some institutional selling.
The news is likely supportive for Oscar Health near term, as profitability and growth signals outweigh ongoing subscriber headwinds
Similar Companies in Healthcare
Other companies in the same sector with AI ratings